Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 5XA2J | — |
patient received a dose of Bexsero after the cap was removed and needle attached and stored for less than 24 hours; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number 5XA2J, expiry date 31-MAY-2028) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incorrect storage of drug (Verbatim: patient received a dose of Bexsero after the cap was removed and needle attached and stored for less than 24 hours). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-AUG-2025 The reporter reported that patient was administered with a dose of Bexsero that was opened and stored for less than 24 hours. The cap was removed a sterile needle was attached. Then it was administered under 24 hours to a 16-year-old male patient. The reporter asked that was this ok for the patient and do patient had to revaccinate.